High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer

Volume: 9, Issue: 4, Pages: 1321 - 1327
Published: Dec 21, 2019
Abstract
Background Programmed death ligand 1 (PD-L1) inhibitor has been approved as one of the standard therapies for various cancers. Some reports have shown that serum PD-L1 level is associated with advanced tumor stages and poor prognosis; however, corresponding pathological information in esophageal cancer patients is lacking. Therefore, we evaluated the clinicopathological and prognostic impact of serum PD-L1 levels in surgically treated esophageal...
Paper Details
Title
High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
Published Date
Dec 21, 2019
Volume
9
Issue
4
Pages
1321 - 1327
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.